Trial Profile
Efficacy of clofarabine in patients with relapsed or refractory acute myelogenous leukemia (AML) and higher-risk myelodysplastic syndromes (MDS) in real world setting.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 02 Dec 2015 New trial record